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Abstract
Background: Studies have shown that public awareness of
ovarian cancer is weak, and women are often diagnosed at late
stages when treatment is difficult. This study aimed to determine
the barriers for seeking early medical care and level of knowledge
and awareness among women regarding ovarian cancer.
Design and methods: A structured questionnaire was designed
and adapted from the validated cancer awareness measure.
Results: The recognition level of ovarian cancer symptoms
among women in this study varied from 12-51%, and the most
alarming ones, back pain, eating difficulties, and persistent
abdominal pain, were missed by most of the surveyed women. The
most recognized ovarian cancer risk factors were never being
pregnant, having a history of infertility, and going through
menopause, while the least recognized was having personal or
family history of breast cancer. Non-UAE nationals women with
higher educational levels had better knowledge of ovarian cancer
compared to their peers.
Conclusions:A change or implementation model is highly rec-
ommended in order to improve women’s awareness of ovarian
cancer symptoms. Strengthening education among women with
regards to risk factors, early symptoms, and the need to seek early
medical help should help to increase ovarian cancer awareness
and reduce a delay in the diagnosis.
Introduction
Ovarian cancer is one of the most challenging gynecological
cancers in the world, with a profound negative effect on the qual-
ity and length of life affecting more than 70% of the women diag-
nosed with advanced disease.1 The absence of specific symptoms
and useful screening tests make it difficult to establish an early
diagnosis of ovarian cancer. In addition, most women have little or
no knowledge about the risks, possible symptoms, and the dangers
ovarian cancer poses to them.1 Worldwide, ovarian cancer is the
seventh most frequent cancer in women, accounting for 3.6% of
various cancers diagnosed in women. It is the third most prevalent
genital tract malignancy after cancers of the cervix and uterus.1
According to the UAE cancer registry report in 2014, ovarian can-
cer is the fifth most commonly diagnosed cancer affecting women
with a prevalence of 4%.2
In the past, ovarian cancer was believed to be a silent killer
due to a lack of symptoms in the early stage leading to late pres-
entation of the disease with its related high mortality rates.3 In the
absence of effective screening, “appropriate clinical suspicion” of
the signs and symptoms of the disease is currently the best strategy
to detect ovarian cancer.4 The hypothesis that ovarian cancer out-
comes could be improved through better symptom recognition has
been primarily advanced by Goff et al. who proposed a “symptom
index” as a tool to screen women for further evaluation for ovarian
cancer. The index is considered positive if pelvic or abdominal
pain, increased abdominal size, bloating, difficulty eating, or early
satiety occur more than 12 times per month but for less than one
year.5 Unfortunately, because these symptoms are non-specific,
they may be attributed to other causes either by the women them-
selves6 or by an inexperienced physician.7 When these symptoms
are detected promptly and investigated appropriately, they may aid
early diagnosis and management, resulting in better prognosis and
outcome for the patients.8 This is because the survival rate of ovar-
ian cancer depends significantly on the stage of the disease with
the early-stage disease having more than a 90% five-year survival
rate compared with less than 30% in advanced stage disease.9 The
Significance for public health
In the absence of effective screening, "appropriate clinical suspicion" of the signs and symptoms of the ovarian cancer is currently the best strategy to detect
the disease. To reduce the diagnostic interval, several countries have implemented referral guidelines and organizational changes. Most of these guidelines sug-
gest that individuals presenting with symptoms indicative of cancer (alarm symptoms) should be urgently referred to specialized investigative trajectories.
However, many studies worldwide have shown that public awareness levels of ovarian cancer are poor, therefore women are often diagnosed at late stages
when treatment is difficult. Our findings demonstrate that the overall level of recognition of risk factors and symptoms of ovarian cancer among women in
the UAE is indeed low and within a critical level. Thus, strengthening education among women with regards to risk factors, early symptoms, and the need to
seek early medical will be helpful in increasing ovarian cancer awareness and reducing the delay in diagnosis.
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risk of developing ovarian cancer is increased with advanced age;
family history of ovarian, breast, uterine, and colon cancer; use of
fertility drugs and nulliparity.9 However, the awareness of these
risk factors and symptoms of ovarian cancer is generally poor
among women.8,9
Several studies have shown that late-stage cancer diagnosis is
associated with reduced survival.10 This is especially the case for
gynecological cancer, and timely diagnosis and treatment are thus
considered essential for prognosis. For most patients with ovarian
cancer, the diagnostic process is still initiated based on symptom
presentation, although some patients are diagnosed through
screening programs.11 To reduce both the patient interval and the
diagnostic interval, several countries have implemented referral
guidelines and organizational changes.12 Most of these guidelines
suggest that individuals presenting with symptoms indicative of
cancer (alarm symptoms) should be urgently referred to special-
ized investigative trajectories.
Many studies worldwide have shown that public awareness
levels of ovarian cancer are poor, and women are often diagnosed
at late stages when treatment is difficult.13,14 Poor public knowl-
edge of early symptoms of cancer has been considered to be the
predominant reason for late-stage presentation or delay in the diag-
nosis.15 The purpose of this study was to determine the level of
knowledge and awareness among women regarding ovarian cancer




This descriptive cross-sectional survey was conducted among
women (aged 20 and above) of all nationalities; from September
2019 until April 2020. 
Study participants and procedure
The participants living in the UAE and willing to provide writ-
ten informed consent were selected for the study. The participants
were assured of the confidentiality of the information provided and
the protection of their rights to privacy, mandated by the research
ethics guidelines of the human research ethics committees. The
inclusion criteria mandated participants to be women aged 20 and
above, who are not health care providers, willing to participate in
the survey and able to sign informed consent, having appropriate
cognitive skills, ability to read and understand in English or Arabic
(e.g., the local language).  Both UAE citizens (nationals) and expa-
triates were included in the study. Participants that had poor mental
health and were unable to meet any of the above criteria were
excluded from the study. The sample size was calculated using epi-
demiological information for a population of 682,000 (population
of females in the UAE), with an alpha of 5% and a 95% confidence
level.  We needed a minimum required sample size of 384.16
Survey design (evaluation tools) 
A structured questionnaire was designed and adapted from the
validated cancer awareness measure (CAM),1 ovarian cancer
awareness measure (ovarian CAM),17 and a questionnaire devel-
oped by the National Ovarian Cancer Coalition.18 The evaluation
tool was then pre-tested among 20 women to assess the ease of
understanding and time required for completion. The bilingual
questionnaire in Arabic and English is represented in APPX I. The
survey instrument consisted of 44 items. The first part of the ques-
tionnaire collected sociodemographic data, including Age,
Nationality, Ethnicity, Marital Status, Education Level,
Employment Status, Monthly Family Income (AED), history of
cancer, Smoking status, and Body Mass Index (BMI). The remain-
ing sections of the questionnaire focused on knowledge and atti-
tude toward ovarian cancer.
Selected questions under ovarian cancer knowledge (30 ques-
tions), and practices (4 questions) were used to develop a scaled
scoring system to categorize these aspects as good, fair, or poor.
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Figure 1. There was a significant difference between educated and non-educated women participants in confidence level regarding
noticing ovarian cancer symptoms. 










Each correct or favorable answer chosen by participants was given
one or two points; then, the points were summed for each partici-
pant. No points were deducted for wrong or unfavorable answers.
The participants’ scoring system was as follows:
- Knowledge: Good (12–18 points), Fair (6–11 points), Poor
(0–5 points)
- Practice: Good (7–10 points), Fair (3–6 points), Poor (0–2
points).
Data analysis and statistics 
All collected data was entered into STATA version 15
(StataCorp. 2017. Stata Statistical Software: Release 15. College
Station, TX: StataCorp LLC.) for statistical analysis. Descriptive
statistics were computed for the socio-demographic variables. The
overall responses to each item of the survey were recorded as a
percentage of the total. The percentage differences in the total
responses were determined using the Chi-square test and statistical
significance recorded for non-parametric data.  For all analyses,
alpha (α) was set at 0.05. We selected only those variables that had
a moderate or higher correlation (>0.40) that was also statistically
significant (p<0.05). A Pearson correlation of 0.00-0.19 is consid-
ered to be very weak, 0.20-0.39 weak, 0.40-0.59 moderate, 0.60-
0.79 strong, and 0.80-1.0 very strong.  We also calculated Φ as an
effect size for all significant correlations (0.0-0.19 is weak, and
0.20-0.49 is moderate and >= 0.50 is strong). 
Results
Out of 602 individuals approached, 532 agreed to participate in
the study (response rate of 88%). The majority of our respondents
were between 25-39 years, UAE national, with middle eastern eth-
nicity, retired or homemakers, had college or higher degrees cer-
tificate, married, had low income, never smokers, and having an
average body mass index (BMI) (Table 1).  Most of our respon-
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Table 1. Descriptive demographic characteristics of participant women (n=532). 










dents have read about ovarian cancer, had regular check-ups with
physicians, did not have a family history of ovarian or breast can-
cer.
It was encouraging that the majority of individuals surveyed
mentioned that they had heard about ovarian cancer; however,
when we assessed their knowledge, the majority had fair or poor
knowledge (Table 2). When evaluating the attitude of participants,
the majority (379, 71%) mentioned that if they notice a symptom
that might be a sign of ovarian cancer, they will visit a doctor with-
in a week. Yet, most of the participants (376, 71%) mentioned that
they are not that confident on noticing an ovarian cancer symptom
and most of the participants did not relate age with the incidence
of cancer.  We calculated Pearson’s correlation coefficient between
variables; a multiple regression model was also fitted to explore
the role of possible predictors of the knowledge score.  There were
no statistically significant predictors of the Knowledge score using
a multiple regression model.
There was a significant difference (p<0.0001) between UAE
nationals and non-UAE nationals on the regard of hearing about
ovarian cancer, having a family history of ovarian cancer
(p<0.0001), and having a family history of breast cancer
(p<0.0001) (Table 3). There was a significant difference between
educated and non-educated women participants in confidence level
regarding noticing ovarian cancer symptoms (Figure 1).  Having a
history of cancer, or having a family member or a friend with
history of cancer was significantly associated with higher ovarian
cancer knowledge score. Reading about ovarian cancer was signif-
icantly associated with BMI (p<0.001) and having a regular check-
up with physicians (p<0.0001). There were no statistically signifi-
cant predictors of the Knowledge score using a multiple regression
model. Knowledge score was only significantly associated with
educational level (p<0.01).
Discussion
Ovarian cancer has been regarded as a “silent killer” due to the
majority of patients being diagnosed at later stages of the disease
(60% at stages III/IV) with low 5-year survival rates (6-22%).19 To
our knowledge, this is the first study conducted in the UAE to eval-
uate the level of awareness among women of ovarian cancer risk
factors, symptoms, and anticipated time to seek early medical help
should they develop suspicious symptoms. The recognition level
of ovarian cancer symptoms among women in the UAE in this
study was varied from 12-51%, and the most alarming ones, back
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Table 2. Knowledge on ovarian cancer among the women participants (n=532). The answers were on Likert scale as a five-point scale;
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pain, eating difficulties, persistent abdominal pain and bloating,
were missed by most of the surveyed population. The most recog-
nized ovarian cancer risk factors among UAE women were never
having been pregnant, having a history of infertility, and going
through menopause, while the least recognized were having a per-
sonal or family history of breast cancer, having ovarian cysts, and
having a genetic predisposition for cancer. Previous studies con-
ducted in several countries, such as USA, Malaysia, Oman, and
Jordan, have shown that knowledge of risk factors of ovarian can-
cer among women was also low as found in our study.1,3,20,21
The observed positive association between education level and
awareness of ovarian cancer risk factors and symptoms indicate
that educated women are in a better position to access and under-
stand information regarding ovarian cancer. It is not surprising that
women with a tertiary level of education had significantly better
knowledge as compared with their counterparts. This is similar to
the findings from other countries, where women with higher levels
of education were more knowledgeable of the symptoms and risk
factors of ovarian cancer.6,22  Thus, education is an essential factor
in increasing awareness of cancer symptoms and predisposing can-
cer risk factors, such as smoking, physical inactivity, obesity, and
an unhealthy diet.23 The role of education in increasing awareness
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Table 3. The relationship between knowledge and practice on ovarian cancer with demographic characteristics among participant










among women of risk factors and symptoms of ovarian cancer in
this study confirms findings from earlier studies conducted world-
wide, which showed that people with higher levels of education
recognized cancer symptoms better than those who were literate
alone or less educated.20 Indeed, previous studies have shown that
a low level of education is associated with a delayed presentation
among breast and colon cancer patients, whereas those with a high-
er level of education showed a greater knowledge of early symp-
toms.15,24
Our study also revealed that women were more knowledgeable
about the risk factors of ovarian cancer compared to its symptoms,
and this is consistent with the findings of another investigation.21
Although participants did better in recognizing ovarian cancer’s
risk factors than its symptoms, it is still evident that they have only
a low knowledge level. Knowledge of ovarian cancer risk factors
is fundamental; it may facilitate participation in screening pro-
grams and early detection.
This emphasizes the potential importance of raising women’s
awareness of the symptoms and risk factors, particularly in a coun-
try like UAE, where low awareness and knowledge levels seem to
be dominant. This could be achieved by using announcements in
the general media and social media channels. Leaflets could be dis-
tributed in local health centers, and hospitals in different regions in
the UAE that might help to increase ovarian cancer awareness.
Investigating potential interventions to increase awareness would
seem to be the next step in our research. Besides, ovarian cancer
awareness programs comprising regular lectures and workshops
for women in general and women in secondary schools and univer-
sities should also be considered. When developing such programs,
specific considerations for a UAE context should be borne in mind.
First, an educational program should target women with low
incomes and low levels of education. Second, these programs
should be freely developed and easily accessible to the former
group at schools, and primary health care centers close to their
homes. To improve women’s awareness of ovarian cancer symp-
toms and change their attitudes toward early detection practice and
programs, using a change or implementation model is highly rec-
ommended.
Conclusions
Our findings demonstrate that the overall level of recognition
of risk factors and symptoms of ovarian cancer among women in
the UAE was low and within a critical level. Thus, strengthening
education among women with regards to risk factors, early symp-
toms, and the need to seek early medical help should help to
increase ovarian cancer awareness and reduce a delay in diagnosis.
Limitation of study
The results of this study are limited due to the cross-sectional
study design; hence, any association found from the results cannot
infer causal relationships. The findings of the study cannot be gen-
eralized for a larger population as the study respondents were
recruited from the Dubai health authority, but could be considered
indicative of the context measured. Nevertheless, a more extensive
national study with recruitment of women from all emirates in the
UAE is needed for better representative sampling.
However, despite these limitations, the present study findings
may be helpful to the health policymakers, health educators, clini-
cians, and nursing professionals in designing the interventions to
increase the knowledge and awareness of women in the UAE on
ovarian cancer symptoms and risk factors. 
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